Dr. Stephen G. Odaibo is Founding Partner of Global AI Experts and CEO and Founder of RETINA-AI Health, Inc. He is a Physician, Retina Specialist, Computer Scientist, Full Stack AI Engineer, and AI/ML expert.

 

Dr. Odaibo completed undergraduate training at University of Alabama (UAB) and medical school at Duke University, where he topped the class in Neurology and Pediatrics and won the Barrie Hurwitz Award for Excellence in Neurology.  He completed ophthalmology residency at Howard and Retina fellowship at University of Michigan.  In addition to his medical training, he holds Masters Degrees in Mathematics and in Computer Science.  In 2017, UAB college of Arts and Sciences awarded him the college’s highest honor--the UAB Distinguished Alumni Achievement Award.  Dr. Odaibo has additionally authored two mathematics textbooks-- "Quantum Mechanics and the MRI Machine" (2012), and of the book "The Form of Finite Groups: A Course on Finite Group Theory" (2016).  

 

Dr. Odaibo has extensive experience in building AI systems and running AI ventures.  Dr. Odaibo is a hands-on full-stack AI/ML engineer and data scientist.  He is a Google Cloud-Certified Professional Cloud Cybersecurity Engineer.  He single-handedly built the world's first mobile AI application for eyecare providers.  He is CEO of RETINA AI—a venture where he and his team designed the RETINA-AI Galaxy software-as-a-Medical-Device for detection of diabetic retinopathy.  As CEO of RETINA-AI, he organized and managed the largest pivotal clinical trial ever done in the United States for an autonomous AI system (clinicaltrials.gov ID: NCT05368623).  His managerial role has garnered him extensive skill in recruitment and management of tech teams.  He additionally has expertise in the regulatory and legal aspects of AI-- Dr. Odaibo was awarded a U.S. patent for inventing an AI system for detecting disease from ophthalmic images.

 

His expertise has been sought out by professional societies across the globe.  Dr. Odaibo has chaired and ran AI workshops at the Medical Device Software Development Summits in the United States (2022, 2023) and European Union (2023).  He has also shared his AI expertise in Asia. In 2019 Dr. Odaibo chaired the "Artificial Intelligence & Tech in Medicine Symposium" at the National Medical Association Meeting. He serves on the Advisory Board of the Duke University Masters of Engineering in Artificial Intelligence program.  He is additionally a board member of Data Science Nigeria—an organization that spearheads AI development and teaching across Africa. 

 

Overall, Dr. Odaibo has extensive experience in AI at the technical, managerial, and regulatory levels.  He continues to provide care for patients part time as a Retina Physician, which gives him first hand access to the implementation and challenges of implementing AI systems. 

 

His extensive experience provides him with a unique platform to advise companies on how to successfully incorporate AI into their business.  His interdisciplinary experience stands to benefit industries across a wide spectrum, including medical devices, pharmaceuticals, banking and finance, logistics, cybersecurity, energy, advanced manufacturing, analytics, commerce, and healthcare.